Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study (Q47597305)

4 February 2018

title

Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study (English)

1 reference

4 February 2018

adaptive radiation therapy

main subject

0 references

author name string

Dubey A

1

1 reference

4 February 2018

Recht A

2

1 reference

4 February 2018

Come SE

3

1 reference

4 February 2018

Gelman RS

4

1 reference

4 February 2018

Silver B

5

1 reference

4 February 2018

Harris JR

6

1 reference

4 February 2018

Shulman LN

7

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

4 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

4 February 2018

volume

45

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

877-884

1 reference

4 February 2018

The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Three-field technique for breast irradiation using tangential field corner blocks.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Effect of delay in radiation in the combined modality treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Six-year results of a multimodality treatment strategy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

Active bone marrow distribution as a function of age in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900295-3

7 January 2021

10.1016/S0360-3016(99)00295-3

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018